[Rheumatic manifestations of parvovirus B19 infection].
Parvoviruses are small single-strand DNA viruses. Human parvovirus (PV B19) was isolated in the 1970s and recognized as a pathogen in the 80s. Its role was first demonstrated in acute erythroblastopenia in patients with chronic haemolytic anaemia, then in epidemic megalerythema. More recently PVB19 has been shown to be the aetiologic agent in fetal loss and chronic infection in immunodepressed patients. Further attention has focused on rheumatologic manifestations, particularly in prolonged joint diseases raising the problem of differential diagnosis and a possible pathogenic relationship with rheumatoid arthritis and systemic lupus erythematosus. Clinically, subjects with parvovirus B19 infection have flu-like manifestations of joint pain and myalgia lasting for about 1 week. Generally, the joint pain is symmetrical, of inflammatory type usually involving proximal joints (phalangeal joints in two-thirds of the cases). Acute back pain or associated extra-articular signs are often absent. Signs regress spontaneously in 10 to 15 days although longer periods have been observed. Diagnosis can be confirmed by ELISA identification of specific IgM antibodies. Nonsteroid antiinflammatory drugs are generally effective.
Wendling
D
D
Service de Rhumatologie, Hôpital J. Minjoz, Besançon.
Lorge
J F
JF
Kremer
P
P
D000328:Adult; D001168:Arthritis / Q000209:etiology; D001172:Arthritis, Rheumatoid / Q000209:etiology; D002648:Child; D016731:Erythema Infectiosum / Q000150:complications* / Q000175:diagnosis; D005260:Female; D006801:Humans; D008297:Male; D012216:Rheumatic Diseases / Q000209:etiology*; D013997:Time Factors
Les manifestations rhumatologiques de l'infection à parvovirus B19.